Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Aug 28, 2012 02:11 PM

Start: Oct 11, 2012 05:15 PM

[image reference is broken]

Speaker: Jo Goodson - Founder, Any Friend Of Ours Ltd
Jo Goodson started her career in and around the software industry in 1999 when she joined Broderbund as their second European employee and grew revenues from £0 to £12m in three years.

She then went on to co-found MediaGold, which, with further offices and bases in France, Italy, Spain and Germany, created an entity that gave US software publishers access to the European market place. She sold that business to Avanquest in 2003 following years of solid growth and profitability.